N. A. Totolyan - Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)

T. O. Simaniv, K. Z. Bakhtiyarova, А. Н. Белова, З. А. Гончарова, S.A. Sivertseva,Н Н Спирин,Natalia Totolyan, T. N. Trushnikova, Е Л Турова, Т И Хайбуллин, Marika Sherman,Alexey Boyко

Nevrologiâ, nejropsihiatriâ, psihosomatika (2023): 71-75

引用0浏览0引用

[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]

A N Boyko,K Z Bakhtiyarova,O V Boyko,V A Dudin,L G Zaslavskii,N A Malkova,E V Parshina,I Ye Poverennova,S A Sivertseva,N A Totolyan,S G Shchur,F A Khabirov,

Zh Nevrol Psikhiatr Im S S Korsakova（2023）

引用0浏览0WOS引用

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Amit Bar-Or,Heinz Wiendl,Xavier Montalban,Enrique Alvarez,Maria Davydovskaya,Silvia R Delgado,Evgeniy P Evdoshenko,Natasa Giedraitiene,Katrin Gross-Paju,Sulev Haldre, Craig E Herrman,Guillermo Izquierdo,

MULTIPLE SCLEROSIS JOURNAL（2022）

引用23浏览0WOS引用

Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy

V. S. Krasnov, K. Z. Bakhtiyarova,E. P. Evdoshenko,D. S. Korobko,T. O. Simaniv,N. A. Totolyan, N. V. Khachanova, M. V. Shumilina, M. V. Davydovskaya

Neurology, Neuropsychiatry, Psychosomatics（2022）

引用0浏览0引用

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

Anne H. Cross,Silvia Delgado,Mario Habek,Maria Davydovskaya,Brian J. Ward,Bruce A. C. Cree,Natalia Totolyan,Ratnakar Pingili,Linda Mancione,Xixi Hu,Roseanne Sullivan,Wendy Su,

Neurol Ther（2022）

引用14浏览0WOS引用

High-dose immunosuppressive therapy with autologous hematopoietic stem cells transplantation for multiple sclerosis: Current view

Alexey Polushin, , Evgeniya Lopatina,Yury Zalyalov, Alexander Tsynchenko,Natalia Totolyan,Alexander Kulagin, , , , ,

Cellular Therapy and Transplantationno. 2 (2022): 6-15

引用0浏览0引用

[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial]

A N Boyko,O V Boyko,K Z Bakhtiyarova,E I Gusev,V A Dudin, L G Zaslavsky,N A Malkova,Ye V Parshina,I Ye Poverennova, S A Siverceva,N A Totolyan,S G Shchur,

Zh Nevrol Psikhiatr Im S S Korsakova（2022）

引用3浏览0WOS引用

Genetic characteristic and clinical features of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

C. C. Cherebillo, V. D. Nazarov, Y. M. Kiryanov, C. V. Lapin,A. V. Mazing, N. V. Shuleshova, G. S. Makshakov,N. A. Totolyan, Y. B. Kushnir, A. V. Cupaeva, V. D. Piven, V. L. Emanuel

Russian neurological journalno. 1 (2022): 32-42

引用1浏览0引用

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: a modern view of the method (review of literature)

A. Yu. Polushin, Yu. R. Zalyalov,N. A. Totolyan,A. D. Kulagin,A. A. Skoromets

The Scientific Notes of the Pavlov Universityno. 4 (2022): 9-21

引用2浏览0引用

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: approaches to risk management

Alexey Yu. Polushin,Yuri R. Zalyalov,Natalia A. Totolyan,Alexander D. Kulagin, Alexander A. Skoromets

Annals of Clinical and Experimental Neurologyno. 3 (2022): 53-64

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn